Posted inMarket
Tidewater Director Kenneth Traub Executes Stock Sale Worth Nearly One Million Dollars
Discover the latest insider trading details as Tidewater director Kenneth Traub unloads shares valued at nearly one million dollars.
Posted inEmerging Market
Indian Rupee Hits Ten-Week High Driven By Strong Inflows
The Indian rupee reached a ten-week closing high against the US dollar, supported by massive market inflows and strong foreign reserve projections.
Posted inMarket
Pulte Accuses Credit Bureaus of Overcharging Americans in Major Industry Critique
Discover the recent accusations against Equifax, Experian, and TransUnion regarding alleged overcharging of American consumers for credit reports.
Posted inMarket
Japanese Yen Heads for Strongest Week as Dollar Holds Steady Before Payrolls
The Japanese Yen is on track for its best week in a month while the US dollar remains flat ahead of crucial nonfarm payroll data.
Posted inMarket
Oil Prices Surge Toward Major Weekly Gains Amid Heightened US-Iran Tensions
Crude oil markets head for significant weekly gains as escalating geopolitical tensions between the United States and Iran threaten global supply.
Posted inMarket
Oil Prices Head for Biggest Weekly Jump Since July Amid US-Iran Tensions
Crude oil is poised for its steepest weekly gain since mid-July driven by escalating geopolitical tensions between the US and Iran.
Posted inMarket
Roku President Mustafa Ozgen Sells Over $530,000 in Company Shares
Roku President Mustafa Ozgen recently sold company stock valued at over $530,000 in a transaction reported to financial regulatory bodies.
Posted inMarket
Permian Resources CFO Sells Shares Valued Over 120,000 Dollars
Permian Resources Executive Vice President and CFO Lee Oliphint recently sold company shares worth 121,209 dollars in a notable insider transaction.
Posted inEmerging Market
JD Vance Addresses US-Iran Conflict Ahead of Midterm Elections
US Vice President JD Vance discusses the ongoing conflict with Iran, avoiding the term war and steering clear of predictions ahead of midterms.
Posted inMarket
PYC Therapeutics Q3 2026 Earnings Beat Expectations Driven by Strong Trial Data
Discover how PYC Therapeutics surpassed Q3 2026 earnings per share estimates, fueled by positive clinical trial results and an upgraded outlook.
